Brief: Polyphor: Enrollment Of First Patient In PRISM-UDR Clinical Trial

Spexis AG

16/04/2019 06:09

April 16 (Reuters) - POLYPHOR AG  POLN.S :
    * POLYPHOR ANNOUNCES ENROLLMENT OF FIRST PATIENT IN
PRISM-UDR -
THE SECOND, FDA AGREED - PHASE III CLINICAL TRIAL FOR
MUREPAVADIN IN PATIENTS WITH NOSOCOMIAL PNEUMONIA

Source text for Eikon:  ID:nEQ7v6Vbxa 
Further company coverage:  POLN.S 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))